Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-08-17 20:21 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-354,670 vol |
25,330 | |
Filed 2023-01-24 15:49 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
380,000 | |
Filed 2022-01-20 18:37 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
280,000 | |
Filed 2021-01-06 20:02 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
230,000 | |
Filed 2020-03-14 13:46 Tx date 2020-03-11 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
180,000 | |
Filed 2020-02-03 11:15 Tx date 2020-01-31 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+65,000 vol |
130,000 | |
Filed 2019-01-03 Tx date 2019-01-02 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
65,000 | |
Filed 2018-08-16 Tx date 2018-08-15 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
25,000 |